What Are the Key Trends in the Global Secukinumab Market?
The Global Secukinumab Market is projected to grow from USD 5,389 million in 2023 to USD 8,445 million by 2034, at a CAGR of 4.3%. This steady growth reflects evolving trends in biologic therapies and autoimmune disease management. The Cosentyx Asia-Pacific Market highlights the increasing role of emerging markets in driving demand. Rising healthcare investments and improved access to advanced...
0 Comments 0 Shares 106 Views 0 Reviews
Sponsored